Equibles does not estimate personal net worth.
Get an email with a short summary when Milestone Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.
Get MIST alertsLorenz Muller has spoken on 4 earnings calls across 1 company, most recently for Milestone Pharmaceuticals Inc. on November 13, 2026. Milestone Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Milestone Pharmaceuticals Inc. includes Joseph Oliveto (CEO and Board Member), Amit Hasija (CFO), Jeffrey Nelson (COO) and 7 others.
“As Joe outlined, the first phase of the launch of Cardamist has given us a much clearer understanding of the market and where we want to focus our resources.”
“Building on Joe's remarks, I will highlight what we are seeing six months into the launch and specifically how we are well positioned to accelerate in the coming months.”
“Building on Joe's overview, I will provide more color on our commercial rollout and sales progress of Cardamist in the first part of the year. Given that it's so early in the launch, I'll break total scripts out by month, which demonstrates steady progress month over month.”
“From a commercial perspective, we're excited to be underway bringing Cardamist, or a trypamil nasal spray, to patients who have not had a new treatment option for literally decades.”
Proxy statement
Start not stated–present
Last confirmed April 30, 2026
Biotechnology · Healthcare
